Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601830-25-000108
Filing Date
2025-06-23
Accepted
2025-06-23 17:23:02
Documents
1
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750713775.html 4  
1 FORM 4 wk-form4_1750713775.xml 4 5738
  Complete submission text file 0001601830-25-000108.txt   7277
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 41 S. RIO GRANDE ST. SALT LAKE CITY UT 84101
Business Address
Bumpus Namandje (Reporting) CIK: 0002060594 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 251065948